411 материалов по теме, собраны автоматически из проверенных источников
AI may help identify breast cancers missed by mammograms, but clinical benefit remains uncertain, UCLA-led review finds The Cancer Letter
Losing Weight and Breast Cancer Risk? The GLP-1 Question The ASCO Post
What Are the Illness-Related Experiences of Male Patients With Breast Cancer? Cancer Nursing Today
FES-PET guides second-line therapy decisions in breast cancer AuntMinnie
The FDA approved combination imlunestrant plus abemaciclib for adults with hormone therapy-resistant estrogen receptor-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer. The combination therapy (Inluriyo and Verzenio, Eli Lilly & Co.) was approved with the indication for certain patients with…
U.S. FDA approves Inluriyo in combination with Verzenio for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer Investing News Network
Researchers at Wake Forest University School of Medicine have identified a protein that may help an aggressive form of breast cancer spread to the brain and escape the body's immune defenses.
Researchers uncover how aggressive breast cancer may spread to the brain | Newswise Newswise
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer Business Wire
Breast cancer has launched a new revolution in precision therapy. eu.36kr.com
A new study published in the journal npj Breast Cancer demonstrates that an artificial intelligence (AI) model offers more accurate predictions of recurrence risk in patients with early-stage breast cancer than the widely used 21-gene Recurrence Score. This research, conducted by a team from the ECOG-ACRIN Cancer…
Wait Times for Cancer Treatment Keep Getting Longer, Study Finds Breast Cancer.org